KVP Capital Advisors »

Achieve Life Sciences shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.3M 462k 4.97

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Achieve Life Sciences

Franklin Resources
Propel Bio Management
Vanguard Group
Simplify Asset Management
Marshall Wace
Nantahala Capital Management
LPL Financial
Geode Capital Management
Pathstone Holdings
KVP Capital Advisors
Susquehanna International
Raymond James Financial
Clearline Capital
Goldman Sachs Group
Two Sigma Investments

View all funds holding Achieve Life Sciences